Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

BAX
Baxter International Inc.
stock NYSE

At Close
Jul 31, 2026 3:59:59 PM EDT
26.15USD-2.243%(-0.60)9,281,519
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 31, 2026 9:26:30 AM EDT
27.00USD+0.935%(+0.25)2,331
After-hours
Jul 31, 2026 4:40:30 PM EDT
26.05USD-0.382%(-0.10)1,803,808
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 7, 2022
03:13PM EST  What 4 Analyst Ratings Have To Say About Baxter Intl   Benzinga
01:01PM EST  Morgan Stanley Upgrades Baxter Intl to Overweight, Raises Price Target to $110   Benzinga
Jan 6, 2022
04:15PM EST  Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors   Business Wire
Jan 4, 2022
07:36AM EST  Raymond James Maintains Outperform on Baxter Intl, Raises Price Target to $99   Benzinga
07:19AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
04:33AM EST  Keybanc Maintains Overweight on Baxter Intl, Raises Price Target to $98   Benzinga
Dec 13, 2021
08:43PM EST  S&P Dow Jones Indices said that Alcoa Corp. (AA) will replace Hill-Rom Holdings Inc. (HRC) in the S&P MidCap 400 effective prior to the opening of trading on December 20.   RTTNews
08:04PM EST  Alcoa To Replace Hill-Rom In S&P MidCap 400 Effective Prior To Opening Of Trading On December 20   RTTNews
07:21PM EST  Alcoa Set to Join S&P MidCap 400   PR Newswire
Dec 8, 2021
08:30AM EST  Baxter Presents Data at ASHP Meeting Indicating Machine Learning May Enhance Infusion Pump Programming Safety   Business Wire
Dec 2, 2021
06:41PM EST  Hillrom Shareholders Approve Acquisition By Baxter   RTTNews
06:29PM EST  Hillrom Shareholders Approve Acquisition By Baxter; Hillrom Shareholders Will Receive $156/Share In Cash   Benzinga
05:48PM EST  Hillrom Shareholders Approve Acquisition By Baxter   PR Newswire
Nov 16, 2021
09:08AM EST  Baxter International Inc. (BAX) Declares Quarterly Dividend of $ 0.28 , Record Date 12/3/2021   RTTNews
09:04AM EST  Baxter Declares Quarterly Dividend Of $0.28/shr; Payable On January 3/record December 3   RTTNews
09:00AM EST  Baxter Declares Quarterly Dividend   Business Wire
Nov 15, 2021
08:25AM EST  Baxter Named to Dow Jones Sustainability Indices in Recognition of Continued Commitment to Corporate Responsibility   Business Wire
Nov 11, 2021
09:16AM EST  Baxter International Inc. (BAX) said it will invest about $100 million to expand its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. Construction on the new manufacturing building is expected to begin in 2022 and be completed in 2024.   RTTNews
09:02AM EST  Baxter Announces $100M Investment In BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility   Benzinga
09:02AM EST  Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility   Business Wire
Nov 8, 2021
08:41AM EST  Baxter Highlights New Data Indicating Sharesource Digital Health Platform For Home Dialysis May Improve Survival, Reduce Hospitalizations   Benzinga
Nov 2, 2021
04:15PM EDT  Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference   Business Wire
Oct 29, 2021
09:39AM EDT  Morgan Stanley Maintains Equal-Weight on Baxter Intl, Lowers Price Target to $86   Benzinga
Oct 28, 2021
12:00PM EDT  Looking Into Baxter International's Return On Invested Capital   Benzinga
08:26AM EDT  The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug   Benzinga
07:26AM EDT  Baxter International Inc. (BAX) announced a profit for its third quarter that increased from the same period last year.   RTTNews
07:25AM EDT  Baxter International Sees Q4 Adj. EPS $1.00-$1.04 vs $1.02 Est. FY21 Adj. EPS $3.58-$3.62 vs $3.34B Est.   Benzinga
07:22AM EDT  Baxter International Q3 EPS $1.02 Beats $0.94 Estimate, Sales $3.23B Miss $3.23B Estimate   Benzinga
07:21AM EDT  Baxter International Q3 Adj. EPS $1.02, Consensus $0.94   RTTNews
07:15AM EDT  Baxter Reports Third-Quarter 2021 Results   Business Wire
04:08AM EDT  Earnings Scheduled For October 28, 2021   Benzinga
Oct 24, 2021
11:45AM EDT  The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More   Benzinga
Oct 21, 2021
05:01PM EDT  Baxter Reports CE Mark For NEPHROCLEAR CCL14 Test   Benzinga
05:00PM EDT  Baxter and bioMrieux Announce CE Mark for NEPHROCLEAR(tm) CCL14 Test to Predict Persistent Severe Acute Kidney Injury   Business Wire
Oct 14, 2021
04:04PM EDT  Watching Hillrom, Baxter Shares As Traders Circulate Dealreporter Speculation Showing US Regulators Likely To Watch Growth In In-Home Care Sector   Benzinga
Oct 13, 2021
04:15PM EDT  Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference   Business Wire
Oct 5, 2021
08:25AM EDT  Baxter To Present Critical Care Data At Annual European Society Of Intensive Care Medicines Congress Oct. 3-6, 2021   Benzinga
08:06AM EDT  Baxter Presents Critical Care Data At 34th Annual ESICM LIVES Congress   RTTNews
08:00AM EDT  Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress   Business Wire
Sep 27, 2021
04:05PM EDT  Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors   Business Wire
Sep 23, 2021
11:24AM EDT  Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure   Benzinga
09:22AM EDT  Sterile medication producer Baxter International Inc. (BAX) announced Thursday that the U.S. Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine).   RTTNews
09:03AM EDT  Baxter Reports FDA Approval And Launch Of Ready-to-use Cardiovascular Medicine Norepinephrine In Premix Formulation   RTTNews
09:01AM EDT  Baxter Announces FDA Approval And Launch Of Ready-To-Use Cardiovascular Medicine Norepinephrine In Premix Formulation   Benzinga
09:00AM EDT  Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation   Business Wire
Sep 13, 2021
10:18AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021   Benzinga
07:49AM EDT  Cowen & Co. Upgrades Baxter Intl to Outperform, Announces $98 Price Target   Benzinga
Sep 9, 2021
08:00AM EDT  Miromatrix Welcomes Dr. John Barry as Vice President of Research   GlobeNewswire Inc
Sep 3, 2021
10:01AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 3, 2021   Benzinga
07:22AM EDT  Barclays Upgrades Baxter Intl to Overweight, Raises Price Target to $100   Benzinga
Sep 2, 2021
10:03AM EDT  Price To Earnings Ratio Insights For Baxter Intl   Benzinga
07:53AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Sept. 2, 2021: GME, BAX, ETWO, FCUV, PSTV   Benzinga
07:31AM EDT  Baxter International Inc. (BAX) has agreed to acquire Hillrom (HRC) for $156.00 per share in cash for a total equity value of approximately $10.5 billion. Baxter will also assume Hillrom's outstanding debt and cash, for a total enterprise value of $12.4 billion. The deal is anticipated to close by early 2022.   RTTNews
07:05AM EDT  Baxter To Buy Hillrom For $156/shr Cash   RTTNews
07:01AM EDT  Baxter To Buy Hillrom At $156/Share For Total Purchase Price Of $10.5B   Benzinga
07:00AM EDT  Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally   Business Wire
Aug 30, 2021
08:16AM EDT  Baxter In Advanced Talks For $10B Hill Rom Buyout: WSJ   Benzinga
Aug 29, 2021
10:37PM EDT  Baxter International Inc. (BAX) is in advanced talks to buy Hill-Rom Holdings Inc. (HRC) for about $150 per share, valuing the medical-equipment maker at about $10 billion, the Wall Street Journal reported citing people familiar with the matter.   RTTNews
Aug 24, 2021
11:35AM EDT  FDA Says Baxter Issues Urgent Medical Device Correction For All Spectrum IQ Infusion Pumps   Benzinga
Aug 18, 2021
08:30AM EDT  The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia   Business Wire
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
06:54AM EDT  Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps   Benzinga
Aug 12, 2021
12:12PM EDT  FDA Says Baxter Healthcare Has Recalled Dose IQ Software Version 9.0.X, Cites Software Defect That May Improperly Configure Drug, Fluid Delivery   Benzinga
Aug 11, 2021
07:38AM EDT  Miromatrix Medical Reports Strategic Investors Were Involved In Series C Financing Following IPO: Baxter, CareDx, DaVita; No Size Of Investment Disclosed   Benzinga
07:00AM EDT  Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO.   GlobeNewswire Inc
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 3, 2021
10:27AM EDT  Goldman Sachs Maintains Neutral on Baxter Intl, Lowers Price Target to $80   Benzinga
Aug 2, 2021
04:15PM EDT  Baxter Advances Enterprise Digital Transformation in Collaboration With AWS   Business Wire
04:34AM EDT  Keybanc Maintains Overweight on Baxter Intl, Lowers Price Target to $92   Benzinga
Jul 29, 2021
04:15PM EDT  Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit   Business Wire
08:14AM EDT  CryoLife Reports Sale Of PerClot To Baxter For $68M In Cash   Benzinga
08:09AM EDT  Baxter International Sees FY21 EPS $3.49-$3.55 Vs. $3.51 Est.   Benzinga
08:09AM EDT  Baxter Closes Acquisition Of PerClot Polysaccharide Hemostatic System   RTTNews
08:08AM EDT  Baxter International Q2 EPS $0.80 Beats $0.75 Estimate, Sales $3.10B Miss $3.11B Estimate   Benzinga
08:02AM EDT  CryoLife Announces Sale of PerClot to Baxter   PR Newswire
08:01AM EDT  Baxter Q2 Earnings Marginally Beat Estimates; Revises Upper End Of 2021 EPS Outlook   Benzinga
08:00AM EDT  Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio   Business Wire
07:54AM EDT  While reporting financial results for the third quarter on Thursday, health care company Baxter International Inc. (BAX) updated its earnings, adjusted earnings and sales growth for the full-year 2021. The company also provided outlook for the third quarter.   RTTNews
07:21AM EDT  Baxter International Inc. (BAX) released earnings for its second quarter that climbed from last year.   RTTNews
07:20AM EDT  Baxter Q2 Worldwide Sales $3.1 Bln, Y-o-Y Increase Of 14% On Reported Basis, 9% On Constant Currencyasis   RTTNews
07:15AM EDT  Baxter Reports Second-Quarter 2021 Results   Business Wire
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 28, 2021
12:22PM EDT  Hill Rom Stock Shoots Higher As Baxter In Early Talks To Acquire Company: WSJ   Benzinga
11:51AM EDT  Hill-Rom Rebuffed A $144/Share Bid From Baxter; Baxter In Early Talks To Buy Co   Benzinga
Jul 15, 2021
08:21AM EDT  Baxter International Inc. (BAX) said that it has supported analysis, which demonstrated clinical and economic benefits of effective intraoperative blood management for surgical patients.   RTTNews
08:08AM EDT  Baxter Highlights Findings In a Study Published In The Journal Of Medical Economics   Benzinga
08:07AM EDT  Baxter Supports Analysis Demonstrating Benefits Of Effective Intraoperative Blood Management For Surgical Patients   RTTNews
08:00AM EDT  Baxter Supports Analysis Demonstrating Clinical and Economic Benefits of Effective Intraoperative Blood Management for Surgical Patients   Business Wire
Jul 12, 2021
06:36PM EDT  Baxter International Inc. (BAX) Declares Quarterly Dividend of $ 0.28, Record Date 9/3/2021   RTTNews
06:30PM EDT  Baxter Declares Quarterly Dividend   Business Wire
Jul 8, 2021
08:06AM EDT  Baxter International Releases 2020 Corporate Responsibility Report   RTTNews
08:00AM EDT  Baxter Launches New 2030 Corporate Responsibility Commitment to Advance Environmental, Social and Governance Priorities   Business Wire
Jun 29, 2021
08:05AM EDT  Baxter International Announces Introduction Of Three Scholarship And Grant Programs To Support Black Students   RTTNews
08:00AM EDT  Baxter Announces $1.2 Million in New Scholarships and Grant Funding to Support Students Pursuing Health and Sciences at Historically Black Colleges and Universities in the United States   Business Wire
Jun 15, 2021
04:15PM EDT  Baxter to Host Second-Quarter 2021 Financial Results Conference Call for Investors   Business Wire
Jun 2, 2021
08:38AM EDT  Baxter Launches Sharesource Analytics 1.0 Digital Health Module   Benzinga
May 25, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021   Benzinga
08:05AM EDT  Baxter Launches PrisMax 2 System To Advance Critical Care Delivery For Patients And Hospitals   RTTNews
06:48AM EDT  Barclays Initiates Coverage On Baxter Intl with Equal-Weight Rating, Announces Price Target of $93   Benzinga
May 10, 2021
04:44PM EDT  FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic   Benzinga
May 4, 2021
04:15PM EDT  Baxter to Present at the UBS Global Healthcare Virtual Conference   Business Wire
May 3, 2021
05:06PM EDT  Baxter Boosts Quarterly Cash Dividend To $0.28/Shr; Record June 4/Payable July 1   RTTNews
05:06PM EDT  Baxter International Inc. (BAX) Declares Quarterly Dividend of $ 0.28, Record Date 6/4/2021   RTTNews
05:00PM EDT  Baxter Increases Dividend and Declares Quarterly Dividend   Business Wire
Apr 30, 2021
07:09AM EDT  Citigroup Maintains Buy on Baxter Intl, Raises Price Target to $98   Benzinga
Apr 29, 2021
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
07:54AM EDT  Baxter International Inc. (BAX) said it expects U.S. GAAP earnings of $0.54 to $0.57 per share and adjusted earnings, before special items, of $0.72 to $0.75 per share for second-quarter 2021. Analysts polled by Thomson Reuters expect the company to report earnings of $0.78 per share for the second-quarter. Analysts' estimates typically exclude special items.   RTTNews
07:27AM EDT  Baxter International Inc. (BAX) announced a profit for first quarter that declined from the same period last year.   RTTNews
07:19AM EDT  UPDATE: Baxter Raises FY21 Adj. EPS Guidance From $3.35-$3.43 To $3.47-$3.55 vs $3.40 Estimate   Benzinga
07:18AM EDT  Baxter International Q1 EPS $0.76 Beats $0.65 Estimate, Sales $2.95B Beat $2.90B Estimate; Raises Guidance   Benzinga
07:17AM EDT  Baxter Q1 EPS $0.58 Vs $0.64 Last Year   RTTNews
07:15AM EDT  Baxter Reports First-Quarter 2021 Results   Business Wire
04:10AM EDT  Earnings Scheduled For April 29, 2021   Benzinga
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 21, 2021
09:45AM EDT  Baxter Recognized Globally for Inclusion Efforts   Business Wire
08:37AM EDT  Baxter Says Receives Grant From German Federal Ministry Of Education And Research To Lead Extracorporeal Blood Purification Research; Amount Not Disclosed   Benzinga
08:04AM EDT  Baxter Receives New R&D Grant From The German Federal Ministry Of Education And Research   RTTNews
08:00AM EDT  Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research   Business Wire
Apr 7, 2021
04:15PM EDT  Baxter to Present at the BofA Securities 2021 Virtual Health Care Conference   Business Wire
Mar 30, 2021
04:15PM EDT  Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format   Business Wire
Mar 29, 2021
10:00AM EDT  Baxter Launches Initiative to Increase Awareness and Education in Black Communities About Kidney Health and Managing Chronic Kidney Disease   Business Wire
Mar 24, 2021
04:15PM EDT  Baxter to Host First-Quarter 2021 Financial Results Conference Call for Investors   Business Wire
Mar 12, 2021
09:29AM EST  Baxter's AK 98 Hemodialysis Machine Ok'd In US   Benzinga
08:26AM EST  Baxter International Inc. (BAX) said Friday that it has received U.S. FDA 510(k) Clearance for its next-generation Artificial Kidney 98 dialysis machine. It is designed to be a portable and easy-to-use system to administer hemodialysis or HD treatments.   RTTNews
08:05AM EST  Baxter Announces FDA Clearance Of Next-generation Artificial Kidney 98 Dialysis Machine   RTTNews
08:01AM EST  Baxter Announces US FDA 510(k) Clearance Of AK 98 Hemodialysis Machine   Benzinga
Mar 10, 2021
04:15PM EST  Baxter to Present at Oppenheimer 31st Annual Healthcare Conference   Business Wire
Mar 8, 2021
10:21AM EST  Baxter To Offer Fill/Finish Services To Moderna's COVID-19 Vaccine In US   Benzinga
09:21AM EST  A Look Into Baxter's Debt   Benzinga
09:21AM EST  Baxter International Inc. (BAX) and Moderna Inc. ( MRNA) said that they have reached an agreement by which Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for about 60-90 million doses of the Moderna COVID-19 Vaccine in 2021. Additional details of the agreement were not disclosed.   RTTNews
09:04AM EST  Baxter BioPharma Solutions, Moderna Enter Agreement For Fill/Finish Manufacturing Of COVID-19 Vaccine In US   RTTNews
09:01AM EST  Moderna, Baxter BioPharma Solutions Announce Agreement For Fill/Finish Manufacturing Of Moderna COVID-19 Vaccine In The U.S.   Benzinga
09:00AM EST  Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.   Business Wire
Feb 16, 2021
04:33PM EST  Baxter Appoints David Wilkes To Its Board   RTTNews
04:30PM EST  Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director   Business Wire
09:10AM EST  Baxter International Inc. (BAX) Declares Quarterly Dividend of $ 0.245, Record Date 2/26/2021   RTTNews
09:04AM EST  Baxter Declares Quarterly Cash Dividend Of $0.245/Shr; Record February 26/Payable April 1   RTTNews
09:00AM EST  Baxter Declares Quarterly Dividend   Business Wire
Feb 5, 2021
09:34AM EST  Credit Suisse Maintains Outperform on Baxter International, Lowers Price Target to $95   Benzinga
07:46AM EST  Raymond James Maintains Outperform on Baxter International, Lowers Price Target to $85   Benzinga
Feb 4, 2021
08:35AM EST  Earnings Scheduled For February 4, 2021   Benzinga
07:41AM EST  Recap: Baxter International Q4 Earnings   Benzinga
07:25AM EST  Baxter International Inc. (BAX) said, for full-year 2021, the company expects sales growth of 7% to 8% on a reported basis and 4% to 5% on a constant currency basis. The company expects adjusted earnings, before special items, of $3.35 to $3.43 per share.   RTTNews
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
07:18AM EST  Baxter Q4 EPS $0.33; Adj EPS $0.80   RTTNews
07:17AM EST  Baxter Sees Q1 Adj. EPS $0.63-$0.65 vs $0.72 Estimate; FY21 Adj. EPS $3.35-$3.43 vs $3.48 Est.   Benzinga
07:16AM EST  Baxter International Q4 Adj. EPS $0.80 Beats $0.76 Estimate, Sales $3.20B Beat $3.04B Estimate   Benzinga
07:15AM EST  Baxter Reports Fourth-Quarter and Full-Year 2020 Results   Business Wire
Jan 30, 2021
01:19PM EST  The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More   Benzinga
Jan 29, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021   Benzinga
07:50AM EST  10 Biggest Price Target Changes For Friday   Benzinga
06:10AM EST  Piper Sandler Downgrades Baxter International to Neutral, Lowers Price Target to $80   Benzinga
Jan 21, 2021
04:15PM EST  Baxter to Present at SVB Leerink 10th Annual Global Healthcare Conference   Business Wire
Jan 11, 2021
08:34AM EST  Baxter BioPharma Solutions Enters Agreement To Provide Sterile Manufacturing Services For NVX-CoV2373   RTTNews
08:30AM EST  Baxter Biopharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine   Business Wire
Jan 5, 2021
04:15PM EST  Baxter to Host Fourth-Quarter 2020 Financial Results Conference Call for Investors   Business Wire
Dec 16, 2020
04:15PM EST  Baxter to Present at the 39th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 15, 2020
11:25AM EST  Morgan Stanley Maintains Equal-Weight on Baxter International, Raises Price Target to $90   Benzinga
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
Dec 3, 2020
08:08AM EST  AdventHealth Tampa To Realize $200,000 In Annual Savings Through Its Involvement In Baxter's Vital Edge Program   RTTNews
08:00AM EST  Baxter and AdventHealth Tampa Announce Cost Savings Achieved Through Intraoperative Hemostasis Management Program   Business Wire
Dec 1, 2020
01:06PM EST  Baxter Healthcare Recalls Spectrum IQ Infusion Systems With Dose IQ Safety Software Due To Unplanned Shutdown Issues; Says FDA Has Identified Co's Recall Of Products As A Class I Recall   Benzinga
Nov 24, 2020
08:10AM EST  Baxter BioPharma Reports $50M Investment To Expand Sterile Fill/Finish Manufacturing Site In Bloomington, Indiana   Benzinga
08:04AM EST  Baxter Announces $50 Million Expansion Of Sterile Fill/finish manufacturing Facilities In Bloomington   RTTNews
08:00AM EST  Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind.   Business Wire
Nov 23, 2020
08:03AM EST  Baxter Secures FDA 510(k) Clearance Of Homechoice Claria With Sharesource   RTTNews
08:01AM EST  Baxter Announces US FDA 510(k) Clearance Of Homechoice Claria With Sharesource   Benzinga
Nov 18, 2020
04:15PM EST  Baxter to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference   Business Wire
Nov 16, 2020
04:22PM EST  Baxter International Inc. (BAX) Declares Quarterly Dividend of $ 0.245, Record Date 12/4/2020   RTTNews
04:19PM EST  Baxter Declares Quarterly Dividend Of $0.245/share, Payable Jan. 4/ Record Dec. 4   RTTNews
04:16PM EST  Baxter Declares Quarterly Dividend   Business Wire
08:25AM EST  Baxter Publishes Its First Sustainability Accounting Standards Board (SASB) Index and Celebrates Continued Inclusion in the Dow Jones Sustainability Indices (DJSI)   Business Wire
Nov 2, 2020
09:48AM EST  Stifel Maintains Buy on Baxter International, Lowers Price Target to $88   Benzinga
Oct 30, 2020
08:35AM EDT  Morgan Stanley Maintains Equal-Weight on Baxter International, Lowers Price Target to $84   Benzinga
04:48AM EDT  KeyBanc Maintains Overweight on Baxter International, Lowers Price Target to $94   Benzinga
Oct 29, 2020
11:36AM EDT  FDA Says Baxter Has, To Date, Received 16 Serious Injury Reports Related To Sigma Spectrum Infusion Pumps   Benzinga
10:30AM EDT  Baxter Reports Proposed $650 Mln Senior Notes Offering   RTTNews
10:15AM EDT  Baxter Announces Proposed $650 Million Senior Notes Offering   Business Wire
07:40AM EDT  Recap: Baxter International Q3 Earnings   Benzinga
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
07:27AM EDT  Baxter International Inc. (BAX) revealed a profit for third quarter that declined from last year.   RTTNews
07:18AM EDT  Baxter Q3 GAAP EPS $0.69; Adj EPS $0.83   RTTNews
07:17AM EDT  Baxter Sees FY20 Adj. EPS $3.02-$3.05 vs $3.06 Estimate   Benzinga
07:17AM EDT  Baxter International Q3 Adj. EPS $0.83 Beats $0.73 Estimate, Sales $2.97B Beat $2.83B Estimate   Benzinga
07:15AM EDT  Baxter Reports Third-Quarter 2020 Results   Business Wire
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 28, 2020
06:06PM EDT  Notable Earnings Watchlist For Thursday, Oct. 29, 2020 Before Market Open: PCG, NOK, OSTK, KHC, SNY, RCL, K, RL, COHU, CMCSA, ABEV, ALXN, CS, TXT, XYL, YUM, TPR, TAP, SPOT, COP, ALKS, AAN, BAX, TPX, KDP, NEM, BC, APRN, BWA, DNKN, DD, HUN, TAK, BUD   Benzinga
Oct 27, 2020
09:08AM EDT  Baxter Supports New Study Showing Blood Purification With Oxiris On Management Of Severely Ill COVID-19 Patients   RTTNews
09:03AM EDT  Baxter Highlights Findings Of Prospective, Multicenter, Observational Study On Data From OxirisNet Registry Evaluating Severely Ill Patients With COVID-19 In Italy Treated With Extracorporeal Blood Purification   Benzinga
09:00AM EDT  Baxter Supports New Study Showing Blood Purification With Oxiris Filter Set Can Play a Role in the Management of Severely Ill COVID-19 Patients   Business Wire
Oct 15, 2020
04:15PM EDT  Baxter to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference   Business Wire
Oct 14, 2020
08:07AM EDT  Baxter International's Debt Overview   Benzinga
08:06AM EDT  Baxter Supports New Study Showing Nutritional Needs In Critically Ill COVID-19 Patients   RTTNews
08:03AM EDT  Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care   Benzinga
Oct 12, 2020
07:38AM EDT  Raymond James Maintains Outperform on Baxter International, Lowers Price Target to $88   Benzinga
Oct 9, 2020
08:52AM EDT  UBS Maintains Buy on Baxter International, Lowers Price Target to $96   Benzinga
Oct 1, 2020
09:30AM EDT  Benzinga's Top Upgrades, Downgrades For October 1, 2020   Benzinga
07:27AM EDT  Citigroup Upgrades Baxter International to Buy, Announces $94 Price Target   Benzinga
Sep 23, 2020
08:23AM EDT  Baxter International Inc. (BAX) announced the U.S. FDA approval of new formulations of Clinimix Injections and Clinimix E Injections with higher protein for patients requiring parenteral nutrition. These new Clinimix formulations contain up to 80 g/L of amino acids, the highest protein in any multi-chamber bag available in the U.S.   RTTNews
08:04AM EDT  Baxter Announce FDA Approval Of New Formulations Of Clinimix And Clinimix E Injections   RTTNews
08:04AM EDT  Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition   Benzinga
Sep 16, 2020
09:13AM EDT  Baxter Announces Exclusive Distribution Agreement With bioMrieux For Novel Acute Kidney Injury Diagnostic Test In Europe And U.S.   Benzinga
09:05AM EDT  Baxter Announces Distribution Agreement With BioMrieux For Novel Acute Kidney Injury Diagnostic Test In Europe And U.S.   RTTNews
09:00AM EDT  Baxter Announces Exclusive Distribution Agreement With bioMrieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.   Business Wire
Sep 9, 2020
06:47PM EDT  CORRECTING and REPLACING Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors   Business Wire
05:15PM EDT  Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors   Business Wire
Sep 4, 2020
11:27AM EDT  P/E Ratio Insights for Baxter International   Benzinga
10:29AM EDT  Argus Research Downgrades Baxter International to Hold   Benzinga
Aug 31, 2020
08:08AM EDT  Baxter International Inc. (BAX) announced the U.S. Food and Drug Administration or FDA has granted the De Novo application for Theranova, the company's novel dialysis membrane.   RTTNews
07:36AM EDT  Baxter Says US FDA Grants De Novo Application For Its Novel Dialysis Membrane Theranova   RTTNews
07:31AM EDT  Baxter Announces FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy   Benzinga
07:30AM EDT  Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy   Business Wire
Aug 20, 2020
04:15PM EDT  Baxter to Present at the Virtual Morgan Stanley 18th Annual Global Healthcare Conference   Business Wire
Aug 19, 2020
04:15PM EDT  Baxter to Present at the 2020 Wells Fargo Virtual Healthcare Conference   Business Wire
Aug 17, 2020
06:04AM EDT  A Peek Into The Markets: US Stock Futures Rise Following Prior Week's Gains   Benzinga
Aug 14, 2020
05:01PM EDT  Baxter Obtains U.S. FDA Emergency Use Authorization For REgiocit Replacement Solution Used In CRRT   Benzinga
Aug 12, 2020
09:12AM EDT  Baxter International Inc. (BAX) has received Emergency Use Authorizations from FDA forthe company's HF20 Set and ST Set used in continuous renal replacement therapy. Both the HF20 Set and ST Set can be used with the Prismaflex or PrisMax control units.   RTTNews
09:11AM EDT  Baxter Reports Obtained FDA Emergency Use Authorization For HF20 Set, ST Set Used In CRRT During Coronavirus Pandemic   Benzinga
09:05AM EDT  Baxter Secures FDA Emergency Use Authorizations For HF20 Set And ST Set Used In CRRT During Covid-19 Pandemic   RTTNews
09:00AM EDT  Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic   Business Wire
Aug 5, 2020
08:34AM EDT  Baxter International Announces Launch Of PD Excellence Academy   RTTNews
08:30AM EDT  Baxter Introduces Virtual Peritoneal Dialysis Excellence Academy for Nurses in the U.S.   Business Wire
Jul 31, 2020
09:59AM EDT  Raymond James Maintains Outperform on Baxter International, Lowers Price Target to $95   Benzinga
08:01AM EDT  Morgan Stanley Maintains Equal-Weight on Baxter International, Lowers Price Target to $90   Benzinga
Jul 30, 2020
09:37AM EDT  While reporting financial results for the second quarter on Thursday, health care company Baxter International Inc. (BAX) initiated earnings, adjusted earnings and sales growth for the full-year 2020.   RTTNews
07:22AM EDT  Baxter Sees FY20 Adj. EPS $3-$3.10 vs $3.30 Estimate   Benzinga
07:22AM EDT  Baxter International Q2 Adj. EPS $0.64 Misses $0.72 Estimate, Sales $2.72B Miss $2.86B Estimate   Benzinga
07:21AM EDT  Baxter International Inc. (BAX) revealed earnings for second quarter that dropped from the same period last year.   RTTNews
07:20AM EDT  Baxter Q2 EPS $0.48 Vs $0.60 Last Year   RTTNews
07:15AM EDT  Baxter Reports Second-Quarter 2020 Results   Business Wire
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 29, 2020
08:33AM EDT  Baxter Int'l. Reports Partnership With Ayogo For Digital Health Solutions For Home Dialysis   Benzinga
08:32AM EDT  Baxter And Ayogo Announce Partnership For Digital Health Solutions For Home Dialysis   Benzinga
Jul 24, 2020
08:33AM EDT  Baxter And VIPUN Medical Announce Collaboration To Commercialize Innovative Gastric Monitoring System   RTTNews
08:30AM EDT  Baxter and VIPUN Medical Announce Collaboration to Commercialize Innovative Gastric Monitoring System to Help Enhance Clinical Nutrition   Business Wire
Jul 15, 2020
08:45AM EDT  Baxter Ranks in Top 10% on 2020 Disability Equality Index   Business Wire
Jul 14, 2020
08:38AM EDT  Baxter International Inc. (BAX) Declares Quarterly Dividend of $ 0.245, Record Date 8/31/2020   RTTNews
08:33AM EDT  Baxter Declares Quarterly Cash Dividend Of $0.245/Shr; Record August 31/payable Oct 1   RTTNews
08:30AM EDT  Baxter Declares Quarterly Dividend   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC